The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Krause Kevin Michael since 2024.
This trader's CIK number is 1916925.
At the time of last reporting, Krause Kevin Michael was the Chief Strategy Officer of An2 Therapeutics, Inc.. (stock ticker symbol ANTX).
Also see all insider trading activities at An2 Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ANTX | 0 | $0 | 10,000 | $201,337 | 10,000 | $27,117 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-09 | ANTX | Sale | 7,417 | 20.14 | 149,370 |
| 2024-01-09 | ANTX | Option Ex | 7,417 | 3.51 | 26,033 |
| 2024-01-02 | ANTX | Sale | 2,583 | 20.12 | 51,967 |
| 2024-01-02 | ANTX | Option Ex | 2,583 | .42 | 1,084 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Krause Kevin Michael (Chief Strategy Officer of An2 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.